Osaic Holdings’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.7K Sell
40,440
-26
-0.1% -$52 ﹤0.01% 4705
2025
Q4
$55.4K Hold
40,466
﹤0.01% 5158
2025
Q3
$45.8K Hold
40,466
﹤0.01% 5369
2025
Q2
$45.7K Buy
40,466
+7,466
+23% +$9.92K ﹤0.01% 5116
2025
Q1
$48.2K Buy
33,000
+12,310
+59% +$23.2K ﹤0.01% 4748
2024
Q4
$44.1K Buy
20,690
+2,240
+12% +$5.53K ﹤0.01% 4803
2024
Q3
$51.7K Sell
18,450
-301
-2% -$802 ﹤0.01% 4722
2024
Q2
$43.7K Buy
18,751
+8,357
+80% +$24.7K ﹤0.01% 4787
2024
Q1
$46.5K Sell
10,394
-1,605
-13% -$6.7K ﹤0.01% 4805
2023
Q4
$38.5K Sell
11,999
-201
-2% -$570 ﹤0.01% 5069
2023
Q3
$38.7K Buy
12,200
+8,780
+257% +$38.5K ﹤0.01% 5169
2023
Q2
$17K Sell
3,420
-4,745
-58% -$25.7K ﹤0.01% 5678
2023
Q1
$40.3K Sell
8,165
-4,423
-35% -$28.4K ﹤0.01% 5096
2022
Q4
$79K Sell
12,588
-5,521
-30% -$51.1K ﹤0.01% 4621
2022
Q3
$196K Sell
18,109
-9,529
-34% -$129K ﹤0.01% 3765
2022
Q2
$315K Buy
27,638
+16,270
+143% +$144K ﹤0.01% 3378
2022
Q1
$103K Buy
11,368
+640
+6% +$6.67K ﹤0.01% 4576
2021
Q4
$160K Buy
10,728
+359
+3% +$6.33K ﹤0.01% 4155
2021
Q3
$266K Buy
10,369
+2,231
+27% +$53K ﹤0.01% 3643
2021
Q2
$212K Buy
8,138
+2,107
+35% +$60.1K ﹤0.01% 3818
2021
Q1
$214K Buy
6,031
+1,862
+45% +$62.8K ﹤0.01% 3669
2020
Q4
$105K Buy
4,169
+2,369
+132% +$77.2K ﹤0.01% 3999
2020
Q3
$68K Buy
1,800
+124
+7% +$4.67K ﹤0.01% 4087
2020
Q2
$72K Sell
1,676
-1
-0.1% -$36 ﹤0.01% 3921
2020
Q1
$33K Buy
+1,677
New +$39.9K ﹤0.01% 4290

Other funds holding ALLO